{
  "case_id": "Case_11",
  "model_id": "openai/gpt-4o",
  "content": "```json\n{\n    \"primary_diagnosis\": {\n        \"name\": \"G6PD Deficiency-induced Hemolytic Anemia\",\n        \"confidence\": 0.9,\n        \"icd_code\": \"D55.0\",\n        \"reasoning\": \"The patient is of Middle Eastern descent, which increases the likelihood of G6PD deficiency. Symptoms of jaundice, dark urine, and splenomegaly are consistent with hemolytic anemia. The recent start of semaglutide may have triggered hemolysis in the context of G6PD deficiency.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Drug-induced Hepatitis\",\n            \"confidence\": 0.6,\n            \"icd_code\": \"K71.6\",\n            \"reasoning\": \"The onset of jaundice and liver-related symptoms could be due to a reaction to semaglutide, leading to liver inflammation.\"\n        },\n        {\n            \"name\": \"Autoimmune Hemolytic Anemia\",\n            \"confidence\": 0.4,\n            \"icd_code\": \"D59.1\",\n            \"reasoning\": \"Symptoms align with hemolytic anemia; however, autoimmune causes are less common but should be considered if G6PD is ruled out.\"\n        },\n        {\n            \"name\": \"Acute Viral Hepatitis\",\n            \"confidence\": 0.3,\n            \"icd_code\": \"B19.9\",\n            \"reasoning\": \"Jaundice and dark urine are also indicative of viral hepatitis, but the temporal relation with semaglutide initiation makes this less likely.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Jaundice and dark urine\",\n        \"Middle Eastern descent with potential G6PD deficiency\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"G6PD level\",\n            \"purpose\": \"To confirm G6PD deficiency\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Liver function tests\",\n            \"purpose\": \"To assess liver involvement\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Complete blood count with reticulocyte count\",\n            \"purpose\": \"To evaluate for hemolytic anemia\",\n            \"priority\": \"urgent\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Discontinue semaglutide\",\n            \"Provide supportive care for anemia\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Folic Acid\",\n                \"dose\": \"1 mg\",\n                \"route\": \"PO\",\n                \"duration\": \"Daily\",\n                \"rationale\": \"To support red blood cell production\"\n            }\n        ],\n        \"monitoring\": [\n            \"Monitor hemoglobin levels\",\n            \"Every 12 hours until stabilized\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Hematology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"For further evaluation of hemolytic anemia\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Worsening jaundice\",\n        \"Severe anemia symptoms\"\n    ],\n    \"patient_education\": [\n        \"Inform patient about G6PD deficiency and triggers\",\n        \"Advise on the importance of avoiding certain medications and foods\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"1 week\",\n        \"conditions\": \"Return immediately if symptoms worsen\"\n    },\n    \"confidence_in_assessment\": 0.85,\n    \"uncertainties\": [\n        \"Pending lab results for final confirmation\",\n        \"Potential for other underlying conditions\"\n    ]\n}\n```",
  "latency": 13.420366287231445,
  "timestamp": "2025-08-10T01:26:06.097221",
  "cached_at": "2025-08-10T01:26:06.097237"
}